Review
Accepted on 13 Jul 2026
Oral absorption of high molecular weight Polyethylene Glycols: mechanistic, safety and regulatory insights
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
Type at least 3 characters
117 articles
articles
Systematic Review
Published on 10 Jul 2026
Safety profile of small interfering RNA therapeutics: a systematic review and meta-analysis of randomized controlled trials
in Clinical Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1855572
- 585 views
Systematic Review
Accepted on 24 Jun 2026
Topical retinoids and risk of major congenital malformations and spontaneous abortion: a systematic review and meta-analysis
in Maternal-Fetal Medicine
Frontiers in Drug Safety and Regulation
- 361 views
Review
Published on 16 Jun 2026
Use of public health databases for the early identification of Autism spectrum disorder: a scoping review protocol
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1816967
- 880 views
Review
Published on 11 Jun 2026
The cutaneous mirror: leveraging drug-induced skin phenotypes as early visual risk signals for systemic toxicity, a comprehensive review
in Clinical Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1825005
- 1,386 views
Original Research
Published on 10 Jun 2026
Methodological comparisons for benefit-risk assessment in complex decision-making: applications and insights from a case study
in Pharmaceutical Policy and Regulation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1792441
- 1,106 views
Original Research
Published on 10 Jun 2026
Comprehensive pharmacovigilance assessment of pairwise drug–drug interactions and acute pancreatitis in the FDA adverse event reporting system: focus on incretin-based drugs
in Clinical Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1827098
- 996 views
Original Research
Published on 09 Jun 2026
Evaluating the implementation of intermittent versus continuous fetal heart rate monitoring on intrapartum care and early neonatal outcomes using causal mediational modeling
in Maternal-Fetal Medicine
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1755487
- 945 views
Brief Research Report
Published on 08 Jun 2026
Modafinil and abnormal bleeding in a young lady with narcolepsy: a case report
in Clinical Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1767644
- 1,334 views
Community Case Study
Published on 29 May 2026
Strengthening pharmacovigilance and regulatory capacity in Southern Africa (SPaRCS): achievements, experiences and lessons learned from a participatory action learning project
in Pharmaceutical Policy and Regulation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1765077
- 1,285 views
Original Research
Published on 11 May 2026
Outcomes of post-approval non-interventional safety studies in pregnancy: wide variation demonstrates need for further standardization
in Maternal-Fetal Medicine
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1805759
- 1,072 views
Original Research
Published on 08 May 2026
Colistin use and outcomes in Kuwait public hospitals
in Clinical Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1808461
- 1,059 views
Original Research
Published on 07 May 2026
Global pharmacovigilance reporting: comparative analysis of adverse event obligations across five major regulatory authorities
in Pharmaceutical Policy and Regulation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1821686
- 2,939 views
Editorial
Published on 14 Apr 2026
Editorial: Pandemic preparedness in vaccine safety and regulation
in Vaccine Safety and Regulation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1824880
- 2,378 views
Perspective
Published on 13 Apr 2026
Physiological actions of “medical devices made of natural materials” (such as vegetal matrices) and non-pharmacological actions of “medical devices made of substances” (and as such artificial derivatives) as innovations introduced by Regulation 2017/745
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1807588
- 1,524 views
Systematic Review
Published on 27 Mar 2026
Risk of neurodevelopmental disorders after fetal topiramate exposure: a systematic review
in Maternal-Fetal Medicine
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1761506
- 1,977 views
Systematic Review
Published on 17 Mar 2026
Systematic review of AI-based models in pharmacoepidemiology for adverse drug event prediction and detection
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1773186
- 2,488 views
Original Research
Published on 09 Mar 2026
Federating AI-related regulations for human therapeutics: an AI-enabled, continuously updating regulatory intelligence system
in Pharmaceutical Policy and Regulation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1718379
- 2,027 views
Original Research
Published on 09 Jan 2026
Hepatobiliary adverse drug reactions during treatment with olaparib: an analysis of data from the EudraVigilance reporting system
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1736759
- 2,162 views
- 1 citation
Original Research
Published on 29 Dec 2025
Cohort event monitoring of booster COVID-19 vaccine safety using patient-reported outcomes in pregnant women
in Maternal-Fetal Medicine
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1689349
- 3,172 views
Review
Published on 18 Dec 2025
A narrative review on the environmental impact of medicines: from water analysis and in vivo studies to prescribing appropriateness, based on European and Italian legal frameworks
in Pharmaceutical Policy and Regulation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1681648
- 3,002 views
- 2 citations
Mini Review
Published on 18 Dec 2025
Tokenization techniques for privacy-preserving healthcare data: tokenization nuts and bolts
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1599217
- 3,928 views
Review
Published on 17 Dec 2025
Pharmacovigilance and bioethics: the importance of a neglected relationship
in Pharmaceutical Policy and Regulation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1698515
- 3,511 views
Original Research
Published on 12 Dec 2025
A real-world disproportionality analysis of roflumilast using the US food and drug administration adverse event reporting system data
in Respiratory Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1721656
- 2,805 views